AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2065626_ITM" title="Facts and information about Diabetes May Up Cancer Risk. (Diabetes).">Diabetes May Up Cancer Risk. (Diabetes).</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Diabetes May Up Cancer Risk. (Diabetes).
People with diabetes might be more prone to certain types of cancer and/or cancer death, Linda C. Koo, Ph.D., said at the annual scientific sessions of the American Diabetes Association.
In a literature review of 93 case-control and cohort studies published between 1980 and 2000, Dr. Koo of GlaxoSmith Kline Pharmaceuticals, Collegevile, Pa., found statistically significant associations between diabetes and cancers of the liver (relative risk 2.5) and pancreas (2.5). Both are biologically plausible: ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- GlaxoSmith-Kline.(TRIANGLE)(downsizing)(Brief Article)
- Magazine article from: Business North Carolina April 1, 2005 700+ words
RESEARCH TRIANGLE PARK -- British drug maker GlaxoSmith-Kline plans to cut 250 jobs--about half of them at its research center here and the rest in Philadelphia. The layoffs here--mostly marketing and administrative jobs--are about 2% of its statewide employment.
- Asthma Medication Helps GlaxoSmith-Kline.
- Newspaper article from: Knight Ridder/Tribune Business News February 14, 2002 700+ words
...Tribune Business News Feb. 14--Boosted by the "phenomenal" success of its new asthma treatment, Advair, drugs giant GlaxoSmith-Kline has turned in another strong quarterly performance and, according to chief executive Jean-Pierre Garnier, is in "an...
- Lawsuit, Pharmaceutical Woes Rock GlaxoSmith-Kline's Third-Quarter Earnings.
- Newspaper article from: Knight Ridder/Tribune Business News October 24, 2002 700+ words
...the pharmaceutical industry's health and a new lawsuit that could delay the launch of an impotence drug dragged down GlaxoSmith-Kline's stock despite healthy third-quarter earnings. United Kingdom investors also were disappointed with the fact that...
- Akubio obtained worldwide rights to the intellectual property, equipment and...
- Newspaper article from: Instrument Business Outlook March 15, 2004 700+ words
Akubio obtained worldwide rights to the intellectual property, equipment and know-how related to GlaxoSmith-Kline's (GSK) piezoelectric crystal microbalance sensor system for label-free molecular sensing. GSK Ventures has also taken an equity stake in Akubio.
- Beating bacteria. (Patents).(GlaxoSmith Kline (US) develops beta-lactamase...
- Magazine article from: Chemistry and Industry October 21, 2002 700+ words
Antibiotic resistance is a major problem for modern medicine, as bacteria develop immunity to even the most powerful drugs. But GlaxoSmithKline (GSK). Pennsylvania, has come up with a solution. Antibiotic resistance often involves bacteria that are capable of producing an enzyme called
- CFC-based Inhalers Face Phaseout in New Zealand.(GlaxoSmith Kline)(Brief...
- Newspaper article from: Ozone Depletion Network Online Today April 17, 2002 700+ words
GlaxoSmithKline recently announced it will discontinue the use of chlorofluorocarbon (CFC)- based inhalers to deliver its medications to asthma sufferers in New Zealand markets. The company said it will also discontinue the CFC-based medications becotide and becloforte later this year. The company
- Novel diabetes drugs block glucose reabsorption.(Endocrinology)
- Magazine article from: Internal Medicine News Tucker, Miriam E. September 1, 2007 700+ words
...scientific sessions of the American Diabetes Association suggest that inhibition...which 47 patients with type 2 diabetes who were either drug-naive...of clinical pharmacology at GlaxoSmith-Kline, presented the results of...of 8 patients with type 2 diabetes. In both populations, there...
- Novo nordisk plans manufacturing expansion for insulin in Brazil. (Life...
- Magazine article from: Chemical Market Reporter Krause, Carey June 23, 2003 700+ words
...sales of Novo Nordisk's diabetes care products rose 24 percent...Bank. Growth in the Type 2 diabetes market will be driven by non...s Actos (pioglitazone), GlaxoSmith-Kline's Avandia (rosiglitazone...currently dominates the Type 2 diabetes market. Late state competitive...
